Good point, Bhag (that Thymitaq may be available to people with liver cancer). I thought that Peter Johnson was saying, in his subtle way, that Thymitaq is effective for liver cancer, and is available for license.
Steve F-- Johnson is not a researcher by training, and does not hold a PhD. He _is_ a brilliant business manager and a very credible public speaker. The proxy statement describes him this way: "Peter Johnson, a founder of the Company, has served as a director and as president and chief executive officer of the Company since its inception in 1984. Through 1989, Mr. Johnson held various positions with The Agouron Institute, including executive director. Mr. Johnson received a M.A. from the University of California, San Diego."
To all: would you be happier with a used-car-sales-type in leisure suit and white shoes, waving his arms and screaming, "Who's got the best PI? Try Merck! Try Abbott! Try Roche! We guarantee two logs of viral load suppression, or your first refill is free. So c'mon down! Torrey Pines Blvd...."
I kinda prefer the subtle approach, but then, I'm not real popular on SI -:) |
